Promising Results of Kalydeco and Orkambi for Cystic Fibrosis Presented at European CF Conference
News
Vertex Pharmaceuticals scientists presented positive results from clinical studies evaluating Kalydeco (ivacaftor) and Orkambi (lumacaftor/ivacaftor) at the 39th European Cystic Fibrosis Society (ECFS) Conference June 8-11 in Basel, Switzerland. The presentations included real-world data from ... Read more